Inventor · disambiguated record
Roger M. Ilagan
Also filed as: ILAGAN ROGER · ILAGAN ROGER M · ILAGAN ROGER MARQUEZ
20 granted patents·14 pending applications·143 citations·filing 2009–2025
95Inventor score
Top patents by PatentIndex Score
34 records- 0196US11839631B2Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cellsUNITED THERAPEUTICS CORP·Filed 2020·Granted Dec 12, 2023·3 cites·10 claims
- 0296US11839596B2Treatment of vasculopathy with prostacyclin and mesenchymal stem cellsUNITED THERAPEUTICS CORP·Filed 2021·Granted Dec 12, 2023·3 cites·7 claims
- 0396US11141393B2Treatment of vasculopathy with prostacyclin and mesenchymal stem cellsUNITED THERAPEUTICS CORP·Filed 2018·Granted Oct 12, 2021·9 cites·10 claims
- 0496US10080730B2Treatment of vasculopathy with prostacyclin and mesenchymal stem cellsUNITED THERAPEUTICS CORP·Filed 2014·Granted Sep 25, 2018·23 cites·11 claims
- 0593US10071123B2Treatment of pulmonary arterial hypertension with mesenchymal stem cellsUNITED THERAPEUTICS CORP·Filed 2013·Granted Sep 11, 2018·21 cites·3 claims
- 0693US10016463B2Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cellsUNITED THERAPEUTICS CORP·Filed 2013·Granted Jul 10, 2018·19 cites·16 claims
- 0792US10842823B2Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cellsUNITED THERAPEUTICS CORP·Filed 2018·Granted Nov 24, 2020·8 cites·20 claims
- 0890US8337485B2Cell-scaffold constructsLUDLOW JOHN W·Filed 2009·Granted Dec 25, 2012·23 cites·16 claims
- 0989US12310992B2Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cellsUNITED THERAPEUTICS CORP·Filed 2023·Granted May 27, 2025·0 cites·12 claims
- 1087US12274684B2Treatment of vasculopathy with prostacyclin and mesenchymal stem cellsUNITED THERAPEUTICS CORP·Filed 2023·Granted Apr 15, 2025·0 cites·14 claims
- 1186US8318484B2Isolated renal cells and uses thereofPRESNELL SHARON C·Filed 2009·Granted Nov 27, 2012·13 cites·12 claims
- 1284US10077442B2Bioactive renal cellsBERTRAM TIMOTHY A·Filed 2011·Granted Sep 18, 2018·5 cites·17 claims
- 1383US11666602B2Treatment of pulmonary arterial hypertension with mesenchymal stem cellsUNITED THERAPEUTICS CORP·Filed 2018·Granted Jun 6, 2023·1 cites·20 claims
- 1482US9271824B2Cell scaffold constructsLUDLOW JOHN W·Filed 2012·Granted Mar 1, 2016·6 cites·14 claims
- 1581US2024409941A1Bioactive renal cellsPROKIDNEY·Filed 2024·Application pending·0 cites
- 1681US2024108657A1Isolated renal cells and uses thereofPROKIDNEY·Filed 2023·Application pending·0 cites
- 1780US11066666B2Bioactive renal cellsINREGEN·Filed 2018·Granted Jul 20, 2021·1 cites·15 claims
- 1879US10105392B2Isolated renal cells and uses thereofINREGEN·Filed 2015·Granted Oct 23, 2018·2 cites·18 claims
- 1978US9192629B2Isolated renal cells and uses thereofREGENMEDTX LLC·Filed 2012·Granted Nov 24, 2015·5 cites·16 claims
- 2071US12157887B2Bioactive renal cellsINREGEN·Filed 2021·Granted Dec 3, 2024·0 cites·18 claims
- 2169US2023137713A1Enhancement of msc immunomodulatory properties by treprostinilUNITED THERAPEUTICS CORP·Filed 2022·Application pending·0 cites
- 2268US2025339463A1Pre-conditioned extracellular vesicles and methods of productionUNITED THERAPEUTICS CORP·Filed 2025·Application pending·0 cites
- 2366US10946047B2Extracellular vesicles with enhanced potencyUNITED THERAPEUTICS CORP·Filed 2018·Granted Mar 16, 2021·1 cites·20 claims
- 2464US2018071074A1Cell scaffold constructsINREGEN·Filed 2017·Application pending·0 cites
- 2561US2019117695A1Isolated renal cells and uses thereofINREGEN·Filed 2018·Application pending·0 cites
- 2660US11571444B2Enhancement of MSC immunomodulatory properties by treprostinilUNITED THERAPEUTICS CORP·Filed 2017·Granted Feb 7, 2023·0 cites·16 claims
- 2757US2022218755A1Extracellular vesicles and their usesUNITED THERAPEUTICS CORP·Filed 2022·Application pending·0 cites
- 2856US2021052641A1Pre-conditioned extracellular vesicles and methods of productionUNITED THERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 2955US2021154238A1Extracellular vesicles with enhanced potencyUNITED THERAPEUTICS CORP·Filed 2021·Application pending·0 cites
- 3054US2021008106A1Mitochondrial treatment of organs for transplantationUNITED THERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 3153US2021169939A1Extracellular vesicles and their usesUNITED THERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 3238US2015030657A1Smooth muscle cell constructsLUDLOW JOHN W·Filed 2011·Application pending·0 cites
- 3336US2011123455A1Rational design of regenerative medicine productsPRESNELL SHARON C·Filed 2010·Application pending·0 cites
- 3431US2017360840A1Extracellular vesicles with enhanced potencyUNITED THERAPEUTICS CORP·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →